Active	Status	Sponsor type	Region	Phase	Filter
1 Active 4 Inactive 5 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
ExPEC-4V / J&J, GSK
NCT03819049 / 2020-000657-27: A Study of Three Different Doses of VAC52416 (ExPEC10V) in Adults Aged 60 to 85 Years in Stable Health	Active, not recruiting	1/2	836	Europe, US	ExPEC10V, VAC52416, ExPEC4V, JNJ-63871860, Prevnar 13, Placebo	Janssen Research & Development, LLC	Extraintestinal Pathogenic Escherichia Coli Prevention	06/21	12/24